NO20042839L - Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister - Google Patents

Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister

Info

Publication number: NO20042839L
Authority: NO; Norway
Prior art keywords: adenosine; beta; receptor agonists; adrenergic receptor; pharmaceutical combinations
Prior art date: 2001-12-06

Application number

NO20042839A

Other languages

English (en)

Norwegian (no)

Inventor

Michael Yeaden

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-06

Filing date

2004-07-05

Publication date

2004-07-05

2004-07-05 Application filed by Pfizer filed Critical Pfizer

2004-07-05 Publication of NO20042839L publication Critical patent/NO20042839L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

NO20042839A 2001-12-06 2004-07-05 Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister NO20042839L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0129270.5A GB0129270D0 (en)	2001-12-06	2001-12-06	Pharmaceutical combination
PCT/IB2002/005057 WO2003047598A1 (fr)	2001-12-06	2002-11-28	Combinaisons pharmaceutiques d'agonistes du recepteur a-2a de l'adenosine et du recepteur beta 2 adrenergique

Publications (1)

Publication Number	Publication Date
NO20042839L true NO20042839L (no)	2004-07-05

Family

ID=9927164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042839A NO20042839L (no)	2001-12-06	2004-07-05	Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister

Country Status (37)

Country	Link
EP (1)	EP1455799B1 (fr)
JP (1)	JP2005513041A (fr)
KR (1)	KR100685557B1 (fr)
CN (1)	CN1856314A (fr)
AP (2)	AP2004003082A0 (fr)
AR (1)	AR037634A1 (fr)
AT (1)	ATE293982T1 (fr)
AU (1)	AU2002351066B2 (fr)
BR (1)	BR0214998A (fr)
CA (1)	CA2469085A1 (fr)
CO (1)	CO5580752A2 (fr)
DE (1)	DE60203934T2 (fr)
DK (1)	DK1455799T3 (fr)
EA (1)	EA200400639A1 (fr)
EC (1)	ECSP045132A (fr)
ES (1)	ES2239728T3 (fr)
GB (1)	GB0129270D0 (fr)
GT (1)	GT200200258A (fr)
HN (1)	HN2002000348A (fr)
HR (1)	HRP20040517A2 (fr)
HU (1)	HUP0402540A3 (fr)
IS (1)	IS7280A (fr)
MA (1)	MA27150A1 (fr)
MX (1)	MXPA04005506A (fr)
NO (1)	NO20042839L (fr)
NZ (1)	NZ533054A (fr)
OA (1)	OA12738A (fr)
PA (1)	PA8560701A1 (fr)
PE (1)	PE20030834A1 (fr)
PL (1)	PL370739A1 (fr)
PT (1)	PT1455799E (fr)
SV (1)	SV2004001426A (fr)
TN (1)	TNSN04101A1 (fr)
TW (1)	TWI256388B (fr)
UY (1)	UY27566A1 (fr)
WO (1)	WO2003047598A1 (fr)
ZA (1)	ZA200403966B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100785969B1 (ko) *	2004-05-12	2007-12-14	동아제약주식회사	Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제
US9757395B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
US9757529B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
US10149823B2 (en)	2013-04-30	2018-12-11	Otitopic Inc.	Dry powder formulations and methods of use
CN115919780A (zh)	2017-09-22	2023-04-07	维克图拉公司	含有硬脂酸镁的干粉组合物
US10786456B2 (en)	2017-09-22	2020-09-29	Otitopic Inc.	Inhaled aspirin and magnesium to treat inflammation
JPWO2022050230A1 (fr) *	2020-09-03	2022-03-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003960D0 (en) *	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives

2001
- 2001-12-06 GB GBGB0129270.5A patent/GB0129270D0/en not_active Ceased
2002
- 2002-11-28 AU AU2002351066A patent/AU2002351066B2/en not_active Ceased
- 2002-11-28 AT AT02785778T patent/ATE293982T1/de not_active IP Right Cessation
- 2002-11-28 BR BR0214998-2A patent/BR0214998A/pt not_active IP Right Cessation
- 2002-11-28 WO PCT/IB2002/005057 patent/WO2003047598A1/fr not_active Ceased
- 2002-11-28 JP JP2003548853A patent/JP2005513041A/ja active Pending
- 2002-11-28 NZ NZ533054A patent/NZ533054A/en unknown
- 2002-11-28 HR HR20040517A patent/HRP20040517A2/hr not_active Application Discontinuation
- 2002-11-28 EP EP02785778A patent/EP1455799B1/fr not_active Expired - Lifetime
- 2002-11-28 DE DE60203934T patent/DE60203934T2/de not_active Expired - Fee Related
- 2002-11-28 EA EA200400639A patent/EA200400639A1/ru unknown
- 2002-11-28 HU HU0402540A patent/HUP0402540A3/hu unknown
- 2002-11-28 OA OA1200400164A patent/OA12738A/en unknown
- 2002-11-28 PL PL02370739A patent/PL370739A1/xx not_active Application Discontinuation
- 2002-11-28 CN CNA028244168A patent/CN1856314A/zh active Pending
- 2002-11-28 DK DK02785778T patent/DK1455799T3/da active
- 2002-11-28 MX MXPA04005506A patent/MXPA04005506A/es active IP Right Grant
- 2002-11-28 CA CA002469085A patent/CA2469085A1/fr not_active Abandoned
- 2002-11-28 AP APAP/P/2004/003082A patent/AP2004003082A0/en unknown
- 2002-11-28 KR KR1020047008609A patent/KR100685557B1/ko not_active Expired - Fee Related
- 2002-11-28 ES ES02785778T patent/ES2239728T3/es not_active Expired - Lifetime
- 2002-11-28 PT PT02785778T patent/PT1455799E/pt unknown
- 2002-11-28 AP APAP/P/2004/003053A patent/AP2004003053A0/en unknown
- 2002-11-29 TW TW091134818A patent/TWI256388B/zh not_active IP Right Cessation
- 2002-12-03 HN HN2002000348A patent/HN2002000348A/es unknown
- 2002-12-03 PE PE2002001164A patent/PE20030834A1/es not_active Application Discontinuation
- 2002-12-04 AR ARP020104685A patent/AR037634A1/es unknown
- 2002-12-05 UY UY27566A patent/UY27566A1/es not_active Application Discontinuation
- 2002-12-05 SV SV2002001426A patent/SV2004001426A/es not_active Application Discontinuation
- 2002-12-05 GT GT200200258A patent/GT200200258A/es unknown
- 2002-12-06 PA PA20028560701A patent/PA8560701A1/es unknown
2004
- 2004-05-21 ZA ZA200403966A patent/ZA200403966B/xx unknown
- 2004-05-21 IS IS7280A patent/IS7280A/is unknown
- 2004-06-02 MA MA27710A patent/MA27150A1/fr unknown
- 2004-06-03 CO CO04052108A patent/CO5580752A2/es not_active Application Discontinuation
- 2004-06-04 EC EC2004005132A patent/ECSP045132A/es unknown
- 2004-06-04 TN TNP2004000101A patent/TNSN04101A1/fr unknown
- 2004-07-05 NO NO20042839A patent/NO20042839L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR037634A1 (es)	2004-11-17
TNSN04101A1 (fr)	2006-06-01
AP2004003053A0 (en)	2004-06-30
ATE293982T1 (de)	2005-05-15
IS7280A (is)	2004-05-21
EA200400639A1 (ru)	2004-12-30
CN1856314A (zh)	2006-11-01
SV2004001426A (es)	2004-05-07
ES2239728T3 (es)	2005-10-01
CO5580752A2 (es)	2005-11-30
KR20050044697A (ko)	2005-05-12
JP2005513041A (ja)	2005-05-12
TW200300759A (en)	2003-06-16
AP2004003082A0 (en)	2004-09-30
PL370739A1 (en)	2005-05-30
HN2002000348A (es)	2005-02-04
UY27566A1 (es)	2003-07-31
TWI256388B (en)	2006-06-11
EP1455799A1 (fr)	2004-09-15
HUP0402540A2 (hu)	2005-07-28
DK1455799T3 (da)	2005-06-27
WO2003047598A1 (fr)	2003-06-12
MXPA04005506A (es)	2004-12-10
GT200200258A (es)	2003-08-22
PA8560701A1 (es)	2004-05-07
AU2002351066B2 (en)	2007-10-18
HUP0402540A3 (en)	2008-04-28
PT1455799E (pt)	2005-08-31
HRP20040517A2 (en)	2004-10-31
PE20030834A1 (es)	2003-10-08
ECSP045132A (es)	2004-07-23
EP1455799B1 (fr)	2005-04-27
BR0214998A (pt)	2004-12-28
KR100685557B1 (ko)	2007-02-22
OA12738A (en)	2006-06-29
MA27150A1 (fr)	2005-01-03
DE60203934D1 (de)	2005-06-02
AU2002351066A1 (en)	2003-06-17
GB0129270D0 (en)	2002-01-23
DE60203934T2 (de)	2006-02-23
CA2469085A1 (fr)	2003-06-12
ZA200403966B (en)	2005-06-22
NZ533054A (en)	2007-02-23

Publication	Publication Date	Title
ATE453647T1 (de)	2010-01-15	Adenosin a2a rezeptor antagonisten
NO20035202D0 (no)	2003-11-24	En adenosin A2A reseptoragonist og et antikolinergmiddel i kombinasjon forbehandling av obstruktive luftveissykdommer
NO20024355L (no)	2002-11-12	Nukleosidforbindelser og anvendelser derav
DK1400518T3 (da)	2007-03-26	Heterocycliske forbindelser og lægemidler
DE60110219D1 (de)	2005-05-25	Adenosin a2a rezeptor antagonisten
DK1379224T3 (da)	2009-11-09	Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese
NO20041975L (no)	2005-07-16	Bicyklisk oksopyridin og oksopyrimidinderivater
ATE448238T1 (de)	2009-11-15	3-beta-d-ribofuranosylthiazolo(4,5- delta)pyridimin-nucleoside und ihre verwendung
IL209010A0 (en)	2011-01-31	Use of tnfalpha antibodies and another drug
NO20002359L (no)	2000-07-05	Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
ATE242259T1 (de)	2003-06-15	Adenosin a1-rezeptor agonisten
NO20012013D0 (no)	2001-04-24	5HT1 reseptor agonister og metoclopramid for behandling av migrene
EE200100395A (et)	2002-10-15	(S)-omeprasooli kaaliumisool
ATE358130T1 (de)	2007-04-15	Bicyclische (1,2,4ö-triazol adenosin a2a rezeptor antagonisten
IL163613A (en)	2010-12-30	Partial or full agonists of a1 adenosine receptors and pharmaceutical compositions comprising the same
NO20042272L (no)	2004-07-28	Farmasoytiske blandinger og fremgangsmater for administrering av EP2-reseptor selektive agonister
PT1208100E (pt)	2003-07-31	Antagonistas selectivos de receptores de adenosina a2b
NO20042839L (no)	2004-07-05	Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister
NO20035300D0 (no)	2003-11-28	Aminokinolin- og aminopyridinderivater og deres anvendelse som adenosin A<N>3-ligander
NO20023144D0 (no)	2002-06-28	Kompleks omfattende OCIF og polysakkarid
IL127947A0 (en)	1999-11-30	Pharmaceutical use of adenosine agonists
ATE250621T1 (de)	2003-10-15	Oral aktive a1 adenosin rezeptor agonisten
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
ITMI20022518A1 (it)	2003-06-04	Dispositivo e procedimento per minimizzare ritardo di
NO20034172L (no)	2003-09-19	Bisykliske guanidinderivater og terapeutiske anvendelser derav

Legal Events

Date	Code	Title	Description
2009-06-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application